drugset / Trial / NCT05826119

Intravenous Administration of Magnesium Sulfate in Laparoscopic Hysterectomy Cases

NCT05826119

Completed 60 enrolled Ondokuz Mayıs University
RandomizedParallel-groupDouble-blindSupportive care

Summary

In our study, it was aimed to show the contribution of intraoperative intravenous magnesium sulfate administration to peroperative opioid consumption and postoperative analgesia.

Timeline

Start
2024-01-20
Primary completion
2024-03-30
Completion
2024-06-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 20 mg/kg Intravenous

Indications

No indication recorded.